Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjogren's syndrome.

, , , , ,

Clinical and experimental rheumatology Vol. 35 (4) : 719-720 • Jul 2017

No abstract available for this paper

No clinical trial protocols linked to this paper

Clinical trials are automatically linked when NCT numbers are found in the paper's title or abstract.

PICO extraction requires an abstract.

PMID: 28281461

DOI: 11253 [pii]

Publication Year: 2017

Language: e, n, g

+7 more

No associated datasets or code repositories found for this paper.

Related paper suggestions will be available in future updates.